Brimonidine formulation in polyacrylic acid nanoparticles for ophthalmic delivery

References

• Ahuja A., Khar R. K., Ali J. Mucoadhesive drug delivery systems. Drug Development and Industrial Pharmacy 1997; 23: 489–515
   Web of Science ®Google Scholar
• Al-Mansouri S., Tabbara K. F., Rask-Pedersen E. Lubrithal (Leo viscous eye gel), preeorneal residence time in normal and dry eyes Documenta Ophthalmologica. Advances in Ophthalmology 1994; 88: 187–194
   Google Scholar
• Artursson P. Cell cultures as models for drug absorption across the intestinal mucosa. Critical Reviews in Therapeutic Drug Carrier Systems 1991; 8: 305–330
   PubMed Web of Science ®Google Scholar
• Artursson P., Karlsson J. Correlation between oral absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cell culture. Biochemical and Biophysical Research Communications 1991; 175: 880–885
   PubMed Web of Science ®Google Scholar
• Blanco-Fuente H., Anguianolgea S., Oteroespinar F. J., Blancomendez J. In vitro bioadhesion of carbopol hydrogels. International Journal of Pharmaceutics 1996; 142: 169–174
   Web of Science ®Google Scholar
• Burke J., Schwartz M. Preclinical evaluation of brimonidine. Survey of Ophthalmology 1996; 41: S9–S18
   PubMed Web of Science ®Google Scholar
• Burke J., Manlapaz C., Kharlamb A., Runde E., Padillo E., Spada C. Therapeutic use of α2-adrenoceptor agonists in glaucoma. α2-Adrenergic Receptors: Structure, Function and Therapeutic Implications, S. Lanier, L. Limbird. Harwood Academic Publishers, ReadingUK 1996; 179–187
   Google Scholar
• Calvo P., Alonso M. J., Vila-Jato J. L., Robinson J. R. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. The Journal of Pharmacy and Pharmacology 1996a; 48: 1147–1152
   PubMed Web of Science ®Google Scholar
• Calvo P., Vila-Jato J. L., Alonso M. J. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. Journal of Pharmaceutical Scieces 1996b; 85: 530–536
   PubMed Web of Science ®Google Scholar
• Cantor B. L., Burke J. Drug evaluation: brimonidine. Expert Opinion in Investigational Drugs 1997; 6: 1063–1083
   PubMedGoogle Scholar
• Chen Y. F., Hung P. T., Hsieh J. W., Shein J., Hsiao C. K. The efficacy of brimonidine in preventing intraocular pressure elevation in the provocative test for primary angle-closure glaucoma. Journal of Ocular Pharmacology and Therapeutics 2002; 18: 99–103
   PubMedGoogle Scholar
• De T. K., Hoffman A. S. A reverse microemulsion polymerization method for preparation of bioadhesive polyacrylic acid nanoparticles for mucosal drug delivery: loading and release of timolol maleate. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 2001a; 29: 31–46
   PubMed Web of Science ®Google Scholar
• De T. K., Hoffman A. S. An ophthalmic formulation of a β-adrenoceptor antagonist, levobetaxolol, using polyacrylic acid nanoparticles as carrier: loading and release studies. Journal of Bioactive and Compatible Polymers 2001b; 16: 20–31
   Web of Science ®Google Scholar
• Derick R. J., Robin A. L., Walters T. R., Barnebey H. S., Choplin N., Schuman J., Kelley E. P., Chen K., Stoecker J. F. Brimonidine tartrate: a one-month dose response study. Ophthalmology 1997; 104: 131–136
   PubMed Web of Science ®Google Scholar
• Diebold Y., Herreras J. M., Callejo S., Argueso P., Calonge M. Carbomerversus cellulose-based artificial-tear formulations; morphologic and toxicological effects on a corneal cell line. Cornea 1998; 17: 433–440
   PubMed Web of Science ®Google Scholar
• Genta I., Conti B., Perugini P., Pavanetto F., Spadaro A., Puglisi G. Bioadhesive microspheres for ophthalmic administration of acyclovir. The Journal of Pharmacy and Pharmacology 1997; 49: 737–742
   PubMed Web of Science ®Google Scholar
• Gu J. M., Robinson J. R., Leung S. H. S. Binding of acrylic polymers to mucin/epithelial surface: structure property relationship. Critical Reviews in Therapeutic Drug Carrier Systems 1988; 5: 21–67
   PubMed Web of Science ®Google Scholar
• Harmia T., Speiser P., Kreuter J. Optimization of pilocarpine loading onto nanoparticles by sorption procedures. International Journal of Pharmaceutics 1986; 33: 45–54
   Web of Science ®Google Scholar
• Hidalgo I. J., Raub T. J., Borchardt R. T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96: 736–749
   PubMed Web of Science ®Google Scholar
• Jani R., Gan O., Ali Y., Rodstorm R., Hancock S. Ion exchange resins for ophthalmic delivery. Journal of Ocular Pharmacology 1994; 10: 57–67
   PubMedGoogle Scholar
• Jones D. S., Woolfson A. D., Brown A. F. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. International Journal of Pharmaceutics 1997; 15: 223–233
   Google Scholar
• Katz L. J. Brimonidine tartrate 0.2% twice-daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. American Journal of Ophthalmology 1999; 127: 20–26
   PubMed Web of Science ®Google Scholar
• Kriwet B., Kissel T. Poly(acrylic acid) microparticles widen the intercellular spaces of Caco-2 cell monolayers: an examination by confocal laser scanning microscopy. European Journal of Pharmaceutics and Biopharmaceutics 1996; 42: 233–240
   Web of Science ®Google Scholar
• Lafuente M. P., Villegas-Perez M. P., Mayor S., Aguilera M. E., Miralles I. J., Vidal-Sanz M. Neuroprotective effects of brimonidine against ischemia-induced retinal ganglion. Cell death: a dose response in vivo study. Experimental Eye Research 2002; 74: 181–189
   PubMed Web of Science ®Google Scholar
• Lai R., Hassan D., Chun T. Neuroprotective effect of ocular hypotensive agent brimonidine. Xith Congress of the European Society of Ophthalmology, Budapest, 1997; 439–444
   Google Scholar
• Langer K., Stienker F., Lambrecht G., Mutschler E., Kreuter J. Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery, Part II: arecaidine propargyl ester and pilocarpine loading and in vitro release. International Journal of Pharmaceutics 1997; 158: 211–217
   Web of Science ®Google Scholar
• Laroche L., Arrata M., Brasseur G., Lagoutte F., Le M. Y., Lumbroso P., Mercante M., Normand F., Rigal D., Roncon S. Treatment of dry eye syndrome with lacrimal gel: a randomized multicenter study. Journal Francais d'Ophtalmologie 1991; 14: 321–326
   PubMed Web of Science ®Google Scholar
• Leblamc R. P. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Ophthalmology 1998; 105: 1960–1967
   PubMedGoogle Scholar
• Lee V. H. L., Robinson J. R. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. Journal of Pharmaceutical Sciences 1979; 68: 673–684
   PubMed Web of Science ®Google Scholar
• Lehr C. M., Lee Y. H., Lee V. H. Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit. Investigative Ophthalmology & Visual Science 1994; 35: 2809–2814
   PubMed Web of Science ®Google Scholar
• Losa C., Calvo P., Castro E., Vila-Jato J. L., Alonso M. J. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. The Journal of Pharmacy and Pharmacology 1991; 43: 548–552
   PubMed Web of Science ®Google Scholar
• Luessen H. L., Bohner V., Perard D., Langguth P., Verhoef J. C., Boer A. G., Merkle H. P., Junginger H. E. Mucoadhesive polymers in peroral peptide drug delivery. V. Effect of poly(acrylates) on enzymatic degradation of peptide drugs by intestinal brush border membrane vesicles. International Journal of Pharmaceutics 1996a; 141: 117–128
   Google Scholar
• Luessen H. L., Borchard G., Verhoef J. C., Lehr C. M., Boer A. G., Junginger H. E. Mucoadhesive polymers in peroral peptide delivery. II. Carbomer® and Polycarbophil® are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharmaceutical Research 1995; 12: 1293–1298
   PubMed Web of Science ®Google Scholar
• Luessen H. L., Rentel C. O., Kotze A. F., Lehr C. M., Boer A. G., Verhoef J. C., Junginger H. E. Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil® and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. Journal of Controlled Release 1997; 45: 15–23
   Web of Science ®Google Scholar
• Luessen H. L., Leeuw B. J., Perard D., Lehr C. M., Boer A. G., Verhoef J. C., Junginger H. E. Mucoadhesive polymers in peroral peptide drug delivery. I. Influence of mucoadhesive excipents on the proteolytic activity of intestinal enzymes. European Journal of Pharmaceutical Sciences 1996b; 4: 117–128
   Web of Science ®Google Scholar
• Marner K., Moller P. M., Dillon M., Rask-Pederson E. Viscous carbomer eye drops in patients with dry eyes: efficacy and safety: a randomized, open, crossover, multicentre study. Acta Ophthalmologica Scandinavica 1996; 74: 249–252
   PubMedGoogle Scholar
• Melamed S., David R. Ongoing clinical assessment of the safety profile and efficacy of brimonidine compared with timolol: year-three results. Clinical Therapeutics 2000; 22: 103–111
   PubMed Web of Science ®Google Scholar
• Munk S. A., Harcourt D., Arasasingham P. Analogs of UK 14,304: structural features responsible for α2-adrenoceptor activity. Bioorganic & Medicinal Chemistry Letters 1995; 5: 1745
   Google Scholar
• Nordlund J. R., Pasquale L. R., Robin A. L., Rudikoff M. T., Ordman J., Chen K. S., Walt J. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine. Archivies of Ophthalmology 1995; 113: 77–83
   PubMedGoogle Scholar
• Park H., Robinson J. R. Mechanism of mucoadhesion of poly(acrylic acid) hydrogels. Pharmaceutical Research 1987; 4: 457–464
   PubMed Web of Science ®Google Scholar
• Patton T. F., Robinson J. R. Quantitative precorneal disposition of topical applied piloearpine nitrate in rabbit eyes. Journal of Pharmaceutical Sciences 1976; 65: 1295–1301
   PubMed Web of Science ®Google Scholar
• Peppas N. A., Sahlin J. J. Hydrogels mucoadhesive and bioadhesive materials—a review. Biomaterials 1996; 17: 1533–1561
   Google Scholar
• Rosenthal A. L., Walters T., Berg E. A comparison of the safety and efficacy of brimonidine 0.2%. BID versus TID in subjects with elevated intraocular pressure. Investigative Ophthalmology & Visual Science 1996; 37: S1102
   Google Scholar
• Schuman J. S. Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension. Survey of Ophthalmology 1996; 41: 27–37
   PubMed Web of Science ®Google Scholar
• Schuman J. S., Horwitz B., Choplin N. T., David R., Albracht D., Chen K. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic brimonidine study group. Archives of Ophthalmology 1997; 115: 847–852
   PubMed Web of Science ®Google Scholar
• Serle J. B. A comparison of the safety and efficacy of twice daily brimonidine 0.%2 versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III. [Clinical Trial. Journal Article. Multicenter Study. Randomized Controlled Trial]. Survey of Ophthalmology 1996; 41(Suppl 1)S39–47
   PubMed Web of Science ®Google Scholar
• Shojaei A. H., Li X. L. Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acid and polyethylene glycol monomethylether mono-methacrylate. Journal of Controlled Release 1997; 47: 151–161
   Web of Science ®Google Scholar
• Takeuchi H., Yamamoto H., Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Advances in Drug Delivery Reviews 2001; 47: 39–54
   PubMed Web of Science ®Google Scholar
• Thermes F., Grove J., Rozier A., Plazonnet B., Constancis A., Bunel C., Vairon J. P. Mucoadhesion of copolymers and mixtures containing polyacrylic acid. Pharmaceutical Research 1992a; 9: 1563–1567
   PubMed Web of Science ®Google Scholar
• Thermes F., Rozier A., Plazonnet B., Grove J. Bioadhesion: the effect of poly(acrylic acid) on the ocular bioavailability of timolol. International Journal of Pharmaceutics 1992b; 81: 59–65
   Web of Science ®Google Scholar
• Torris C. B., Camras C. B., Yablonski M. E. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. American Journal of Ophthalmology 1999; 128: 8–14
   PubMedGoogle Scholar
• Tur K. M., Chang H. S. Evaluation of possible mechanism(s) of bioadhesion. International Journal of Pharmaceutics 1998; 1: 61–74
   Google Scholar
• Wallieke P. A. Basic and acidic fibroblast growth factors have tropic effect on neurons from multiple CNS regions. Journal of Neuroscience 1988; 8: 2618–2627
   PubMedGoogle Scholar
• Zimmer A., Mutshler E., Lambrecht G., Mayer D., Kreuter J. Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system. Pharmaceutical Research 1994; 11: 1435–1442
   PubMed Web of Science ®Google Scholar